Drug Profile
Fenofibrate - Ethypharm/Lupin
Alternative Names: Antara; Lipilfen; RP-1824Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Ethypharm
- Developer Daewoong Pharmaceutical; Ethypharm; Lupin
- Class Antihyperlipidaemics; Benzophenones; Butyric acids; Fibric acid derivatives; Propionates; Small molecules
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hyperlipidaemia
Most Recent Events
- 01 Jan 2014 Launched for Hyperlipidaemia in China (PO)
- 22 Oct 2013 Launched for Hyperlipidaemia (30mg and 90mg doses) in USA (PO)
- 22 Oct 2013 Registered for Hyperlipidaemia in USA (PO; 30mg and 90mg)